How do you manage hypothermia caused by gabapentin (Neurontin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Gabapentin-Induced Hypothermia

Immediately discontinue gabapentin and initiate active rewarming measures based on the severity of hypothermia, as drug-induced hypothermia requires prompt removal of the offending agent combined with temperature-directed supportive care.

Immediate Actions

Discontinue the Offending Agent

  • Stop gabapentin immediately upon suspicion of drug-induced hypothermia, as this is the primary intervention for all drug-induced temperature dysregulation syndromes 1, 2
  • Drug-induced hypothermia can be life-threatening and requires prompt recognition and discontinuation of the causative medication 2

Assess Severity and Initiate Rewarming

Mild Hypothermia (32-35°C):

  • Remove wet clothing immediately and move patient to warm environment 3, 4
  • Apply warm blankets and increase environmental temperature 3, 4
  • Provide high-calorie foods or warm drinks if patient is alert 3
  • Allow passive rewarming with insulation 4

Moderate Hypothermia (28-32°C):

  • Continue all mild hypothermia interventions 3
  • Implement active external rewarming: heating pads, forced warm air blankets (Bair Hugger), or chemical heat blankets 3, 4, 2
  • Administer warmed intravenous fluids 3, 4
  • Provide humidified, warmed oxygen 3

Severe Hypothermia (<28°C):

  • Continue all moderate hypothermia measures 3
  • Activate emergency response system 3
  • Consider active core rewarming methods including peritoneal lavage with warmed fluids 4
  • Handle patient gently to avoid triggering cardiac arrhythmias 3

Monitoring and Supportive Care

Temperature Monitoring

  • Assess core temperature every 5-15 minutes depending on severity 3
  • Target minimum core temperature of 36°C before considering transfer 3, 4
  • Cease rewarming after reaching 37°C, as higher temperatures are associated with poor outcomes 3, 4

Complications to Monitor

  • Cardiac arrhythmias during rewarming 3
  • Rewarming shock 3
  • Coagulopathy 3
  • Burns from improper use of active external rewarming devices 3
  • Hypotension and bradycardia (commonly seen with drug-induced hypothermia) 2

Additional Workup

Rule Out Alternative Causes

  • Obtain blood cultures and infection workup with procalcitonin 2
  • Check cortisol levels and thyroid function to exclude endocrinopathy 3, 2
  • Review medication history for other potential causative agents 1

Clinical Pearls

Key Pitfall: Hypothermia is often overlooked during initial resuscitation; emphasis should be on prevention first and treatment second 4. In the case of drug-induced hypothermia, the temporal relationship between medication initiation and symptom onset is critical for diagnosis 1, 2.

Rewarming Rates: Shivering can increase rewarming rates up to 3.6°C/hour, and external rewarming with forced-air warmers can be effective even in severe cases with temperatures below 30°C 4.

Prognosis: Once gabapentin is discontinued, normothermia should be achieved and maintained without continued aggressive rewarming measures, as demonstrated in case reports where temperature stabilized after drug discontinuation 2.

References

Research

Diagnosis and treatment of drug-induced hyperthermia.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013

Guideline

Initial Approach to Treating Chronic Hypothermia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Hypothermia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.